Madrid, Spain

Antonio Urbano-Pujol

This inventor holds 1 USPTO granted patent. Top assignee: L'oreal. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Urbano-Pujol. Retrieved from https://idiyas.com/inventor/antonio-urbano-pujol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Urbano-Pujol: Innovator in Stereospecific Synthesis

Introduction

Antonio Urbano-Pujol is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly in the synthesis of biologically important compounds. His work has implications for various applications in pharmaceuticals and biochemistry.

Latest Patents

Antonio Urbano-Pujol holds a patent for a process for the stereospecific synthesis of leukotriene B.sub.4. This innovative process involves the preparation of a dibenzoate triether, which is subjected to a reductive elimination to obtain a triether that is then converted to yield leukotriene B.sub.4. This compound is crucial for understanding inflammatory responses in the body.

Career Highlights

Antonio is currently employed at L'Oréal, where he applies his expertise in chemistry to advance the company's research and development efforts. His work at L'Oréal showcases the intersection of scientific innovation and commercial application, particularly in the beauty and personal care industry.

Collaborations

Antonio has collaborated with notable colleagues, including Guy Solladie and Guy Stone. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving innovative breakthroughs.

Conclusion

Antonio Urbano-Pujol's contributions to the field of stereospecific synthesis exemplify the vital role of inventors in advancing scientific knowledge and practical applications. His work continues to influence the development of important compounds in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…